JP2023550355A5 - - Google Patents
Info
- Publication number
- JP2023550355A5 JP2023550355A5 JP2023528758A JP2023528758A JP2023550355A5 JP 2023550355 A5 JP2023550355 A5 JP 2023550355A5 JP 2023528758 A JP2023528758 A JP 2023528758A JP 2023528758 A JP2023528758 A JP 2023528758A JP 2023550355 A5 JP2023550355 A5 JP 2023550355A5
- Authority
- JP
- Japan
- Prior art keywords
- lymphocytes
- genetically modified
- lineage
- cell surface
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113739P | 2020-11-13 | 2020-11-13 | |
| US63/113,739 | 2020-11-13 | ||
| US202163229017P | 2021-08-03 | 2021-08-03 | |
| US63/229,017 | 2021-08-03 | ||
| PCT/US2021/059182 WO2022104090A1 (en) | 2020-11-13 | 2021-11-12 | Methods and compositions relating to genetically engineered cells expressing chimeric antigen receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550355A JP2023550355A (ja) | 2023-12-01 |
| JP2023550355A5 true JP2023550355A5 (https=) | 2024-11-21 |
Family
ID=79602283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528758A Pending JP2023550355A (ja) | 2020-11-13 | 2021-11-12 | キメラ抗原受容体を発現する遺伝子操作された細胞に関連する方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230414755A1 (https=) |
| EP (1) | EP4243858A1 (https=) |
| JP (1) | JP2023550355A (https=) |
| KR (1) | KR20230107610A (https=) |
| AU (1) | AU2021380830A1 (https=) |
| CA (1) | CA3201003A1 (https=) |
| WO (1) | WO2022104090A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250026552A (ko) | 2023-08-17 | 2025-02-25 | 현대모비스 주식회사 | 팝업 디스플레이 장치 및 이를 장착한 차량 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4694778A (en) | 1984-05-04 | 1987-09-22 | Anicon, Inc. | Chemical vapor deposition wafer boat |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| JPS6412935A (en) | 1987-07-02 | 1989-01-17 | Mitsubishi Electric Corp | Constant-speed travel device for vehicle |
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| WO2015157070A2 (en) | 2014-04-09 | 2015-10-15 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating cystic fibrosis |
| CA2969619A1 (en) | 2014-12-03 | 2016-06-09 | Agilent Technologies, Inc. | Guide rna with chemical modifications |
| KR102888521B1 (ko) | 2015-04-06 | 2025-11-19 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | Crispr/cas-매개 유전자 조절을 위한 화학적으로 변형된 가이드 rna |
| AU2016337525B2 (en) * | 2015-10-16 | 2022-01-20 | The Trustees Of Columbia University In The City Of New York | Compositions and methods for inhibition of lineage specific antigens |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| US10767175B2 (en) | 2016-06-08 | 2020-09-08 | Agilent Technologies, Inc. | High specificity genome editing using chemically modified guide RNAs |
| CA3048434A1 (en) | 2016-12-30 | 2018-07-05 | Editas Medicine, Inc. | Synthetic guide molecules, compositions and methods relating thereto |
| RU2019130504A (ru) * | 2017-02-28 | 2021-03-30 | Вор Байофарма, Инк. | Композиции и способы ингибирования линиеспецифических белков |
| US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| KR20240116572A (ko) | 2017-03-23 | 2024-07-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제 |
| CA3110837A1 (en) | 2018-08-28 | 2020-03-05 | Vor Biopharma Inc. | Genetically engineered hematopoietic stem cells and uses thereof |
-
2021
- 2021-11-12 EP EP21843800.0A patent/EP4243858A1/en active Pending
- 2021-11-12 JP JP2023528758A patent/JP2023550355A/ja active Pending
- 2021-11-12 WO PCT/US2021/059182 patent/WO2022104090A1/en not_active Ceased
- 2021-11-12 AU AU2021380830A patent/AU2021380830A1/en not_active Abandoned
- 2021-11-12 KR KR1020237019126A patent/KR20230107610A/ko active Pending
- 2021-11-12 CA CA3201003A patent/CA3201003A1/en active Pending
- 2021-11-12 US US18/036,698 patent/US20230414755A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Marcu et al. | 5′ flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains | |
| Förster et al. | Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. | |
| EP3653049B1 (en) | Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same | |
| Kaushik et al. | Murine V kappa gene expression does not follow the VH paradigm. | |
| JP2023055884A5 (https=) | ||
| JP2018531260A5 (https=) | ||
| Fok et al. | The lncRNA connection between cellular metabolism and epigenetics in trained immunity | |
| CN104334732B (zh) | 表达人λ免疫球蛋白轻链可变结构域的动物 | |
| JP2018522072A5 (https=) | ||
| JP2023550355A5 (https=) | ||
| JP2022521486A5 (https=) | ||
| WO2017093370A1 (en) | T-cell specific genome editing | |
| JP2023539361A5 (https=) | ||
| JP2021502085A5 (https=) | ||
| Bascuas et al. | Salmonella immunotherapy improves the outcome of CHOP chemotherapy in non-Hodgkin lymphoma-bearing mice | |
| JP2022521787A5 (https=) | ||
| JP2022517618A5 (https=) | ||
| Kumari et al. | Humanized mouse models for immuno‐oncology drug discovery | |
| JP2022548902A5 (https=) | ||
| SG11202109972QA (en) | Improved process for integration of dna constructs using rna-guided endonucleases | |
| RU2020100919A (ru) | СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ | |
| EP3570668B1 (en) | Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci | |
| JP2022554348A5 (https=) | ||
| JP2024528202A5 (https=) | ||
| Bhat et al. | Contemplating dichotomous nature of gamma delta T cells for immunotherapy |